Correlation Between Co Diagnostics and Vivos Therapeutics

Can any of the company-specific risk be diversified away by investing in both Co Diagnostics and Vivos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Co Diagnostics and Vivos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Co Diagnostics and Vivos Therapeutics, you can compare the effects of market volatilities on Co Diagnostics and Vivos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Co Diagnostics with a short position of Vivos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Co Diagnostics and Vivos Therapeutics.

Diversification Opportunities for Co Diagnostics and Vivos Therapeutics

0.2

Correlation Coefficient

Co Diagnostics  Vivos Therapeutics

Modest diversification

The 3 months correlation between CODX and Vivos is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Co Diagnostics and Vivos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vivos Therapeutics and Co Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Co Diagnostics are associated (or correlated) with Vivos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vivos Therapeutics has no effect on the direction of Co Diagnostics i.e., Co Diagnostics and Vivos Therapeutics go up and down completely randomly.

Pair Corralation between Co Diagnostics and Vivos Therapeutics

Given the investment horizon of 90 days Co Diagnostics is expected to generate 8.53 times more return on investment than Vivos Therapeutics. However, Co Diagnostics is 8.53 times more volatile than Vivos Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Vivos Therapeutics is currently generating about -0.2 per unit of risk. If you would invest  42.00  in Co Diagnostics on September 17, 2025 and sell it today you would lose (16.75) from holding Co Diagnostics or give up 39.88% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	98.44%
Values	Daily Returns

Co Diagnostics  vs.  Vivos Therapeutics

Co Diagnostics

Risk-Adjusted Performance

Soft

Compared to the overall equity markets, risk-adjusted returns on investments in Co Diagnostics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady fundamental indicators, Co Diagnostics showed solid returns over the last few months and may actually be approaching a breakup point.

Vivos Therapeutics

Risk-Adjusted Performance

Weakest

Over the last 90 days Vivos Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2026. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Co Diagnostics and Vivos Therapeutics

The main advantage of trading using opposite Co Diagnostics and Vivos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Co Diagnostics position performs unexpectedly, Vivos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vivos Therapeutics will offset losses from the drop in Vivos Therapeutics' long position.

The idea behind Co Diagnostics and Vivos Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.